feed,title,long_url,short_url
Benzinga,Trillium Therapeutics' CD47 Assets Show Continued Anti-Tumor Activity In Hematologic Malignancies,https://benzinga.com/general/biotech/21/04/20834325/trillium-therapeutics-cd47-assets-show-continued-anti-tumor-activity-in-hematologic-malignancies,https://j.mp/2QH4Whw
